Epidemiology and costs of chronic obstructive pulmonary disease

Chapman K. R., Mannino D. M., Soriano J. B., Vermeire P. A., Buist A. S., Thun M. J., Connell C., Jemal A., Lee T. A., Miravitlles M., Aldington S., Beasley R.

Source: Eur Respir J 2006; 27: 188-207
Journal Issue: January

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Chapman K. R., Mannino D. M., Soriano J. B., Vermeire P. A., Buist A. S., Thun M. J., Connell C., Jemal A., Lee T. A., Miravitlles M., Aldington S., Beasley R.. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease
Source: Eur Respir J, 50 (2) 1602470; 10.1183/13993003.02470-2016
Year: 2017



Costs of chronic obstructive pulmonary disease in Sweden
Source: Eur Respir J 2002; 20: Suppl. 38, 125s
Year: 2002

Telemedicine in chronic obstructive pulmonary disease
Source: Breathe 2016; 12: 350-356
Year: 2016



Diabetes and chronic obstructive pulmonary disease
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019


Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



Genetic risks in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003

Comorbidities in the course of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015


Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009

Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017

The economic burden of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010


Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001

Socioeconomic burden of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463
Year: 2006

Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003


Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010